|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total Current Assets | ||||
| Deferred offering costs | ||||
| Cash and marketable securities held in trust account | ||||
| Total Assets | ||||
| Current Liabilities | ||||
| Promissory note – related party | ||||
| Accrued Expenses | ||||
| Other Payable | ||||
| Total Current Liabilities | ||||
| Deferred underwriting fee | ||||
| Total Liabilities | ||||
| Ordinary share subject to possible redemption, $0.0001 par value; 550,000,000 shares authorized; 6,900,000 shares issued and outstanding, at redemption value of $10.07 as of December 31, 2025 and $10.25 as of June 30,2026, respectively | ||||
| Shareholders’ Equity (Deficit) | ||||
| Ordinary Shares, $0.0001 par value; 550,000,000 shares authorized; 1,928,100 issued and outstanding | ||||
| Additional paid-in capital | ||||
| Retained earnings (Accumulated deficit) | ||||
| Subscription receivable | ||||
| Total Shareholders’ Equity (Deficit) | ||||
| Total Liabilities and Shareholders’ Equity (Deficit) |
Loading...
